Boyds
Dr. Andrew Exley is a seasoned immunologist and regulatory affairs expert with extensive experience in consulting and assessment roles in both the private and public sectors. Currently serving as Co-Director at Adept Biologica Consulting Limited since May 2020, Dr. Exley provides tailored advisory, regulatory, and negotiating services, collaborating with former MHRA and EMA assessors to facilitate product licensing and clinical development. Dr. Exley has held notable positions, including External Consultant in Immunology and Regulatory Affairs at Boyds and Voisin Consulting Life Sciences, and served as a Medical Assessor at the Medicines and Healthcare products Regulatory Agency, where significant contributions were made to clinical trials and immunogenicity assessments. Previous roles include Consultant Immunologist at Royal Papworth Hospital, Senior Registrar at University Hospitals of Birmingham, and Clinical Registrar at St Mary's Hospital. Dr. Exley holds multiple prestigious qualifications, including FRCPath and FRCP, with a foundational education that spans institutions such as the University of Oxford and University of London.
Boyds
At Boyds, our goal is to facilitate the translation of cutting-edge science into medicinal products which benefit patients. We understand how challenging this can be, both technically and commercially. Our service is designed to provide crucial experience and assistance whenever you need it, in order to bring your innovations to the marketplace as quickly and efficiently as possible. Boyds was established in 2005 and provides a range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices. We are headquartered in the UK with offices located in Cheshire and Cambridgeshire and also have offices in Dublin and Pennsylvania. Our consultancy services offer a cost-effective solution for those requiring expert assistance in order to expedite development, add value to their product, and reach those key milestones. Whether it relates to a single issue or a long-term commitment to your development team, we can help you chart the innovative course great science demands.